Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

India faces a challenging global economic outlook for 2026-27. Geopolitical tensions and volatile oil prices are key concerns. However, Ind...

The Union Budget 2026-27 focuses on fortifying the Indian economy against global volatility through strategic investments in technology, he...

Piramal Pharma swung to a Rs 136 crore Q3 loss as revenue fell 3%, hit by CDMO destocking, weak US biopharma funding, trade uncertainty and...

In the letter written on May 13, Arun Kumar, Founder and Director of Stelis Biopharma Limited, said that after the prime minister had reque...

Proceeds from the IPO will be used towards investment in Mobius Biomedical Inc, acquisition of licenses for product development of skincare...

Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...

With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF, which is promoting the ...

The RDIF has signed agreements with several companies to manufacture Sputnik V in India — Virchow Biotech (up to 200 million doses per year...

One of the six, Hetero Biopharma, had last fortnight obtained clearance from the subject expert committee under India’s drug controller to ...

Earlier on April 13 the expert committee had given its approval for the emergency use of Sputnik V. Sputnik V is developed by the Gamalaya ...

Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and He...

Telangana government proposes to set up India’s first Biopharma-Hub to provide support to the biopharma research and development activities.

Avesthagen, Bangalore-based R&D driven biotechnology company, has restructured its operations into four independent profit and loss (P&L) e...